Our commitment to sustainability: a review of an evolving journey
We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved and the challenges ahead. In recent years, we have implemented significant projects, particularly in the field of circular economy, transforming our production cycle. Thanks to these initiatives, we have achieved a 70% reduction in waste production, redirecting over 12,000 tons of by-products annually into new production cycles, keeping materials in value chains as long as possible.
On the social front, we have focused on employee growth and stability: over 97% of our contracts are permanent, and nearly 95% of our staff have participated in training activities. This focus has allowed us to face challenging periods like the pandemic with resilience.
For Sacco System, sustainability is a strategic pillar driving research and innovation, aiming to address global challenges such as food waste reduction and the promotion of sustainable agri-food supply chains.
Starting in 2026, we will comply with the EU’s Corporate Sustainability Reporting Directive (CSRD), a crucial step in consolidating our approach. We are already working on integrated reporting, involving all group companies and updating materiality topics based on the double materiality principle to ensure a business model aligned with stakeholder expectations and environmental and social challenges.
Sacco System will continue to contribute to sustainable development, adapting to an ever-changing context and ensuring a resilient model through dialogue and engagement with all our partners.
Latest News
An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.
The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy
“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been
GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a
Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1
Our commitment to sustainability: a review of an evolving journey We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved
Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the
At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco
Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce
Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries, based on tradition, expertise, research, and innovation which sells and distributes its ingredients in more
We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,
This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration